Intellectual Disability and Psychotropic Medications.

Area of Science:

• Pediatric neurology and developmental medicine
• Genetics and rare diseases
• Behavioral science and psychiatry

Background:

• A 17-year-old male with Down syndrome (trisomy 21) and severe intellectual disability presents for care transition.
• He has a history of congenital heart defects, infantile spasms, and multiple medical comorbidities including G-tube dependency and chronic constipation.
• The primary concern is severe nonsuicidal self-injury (NSSI), including head banging and self-scratching, refractory to over 10 psychotropic medications.

Observation:

• The patient exhibits aggression, irritability, and NSSI, with physical evidence of self-harm.
• Extensive workup, including advanced imaging and metabolic/autoimmune testing, has ruled out common organic causes for his behavior.
• Fragmented care across multiple institutions and significant caregiver burnout complicate management.

Findings:

• Despite a comprehensive workup and behavioral interventions like applied behavior analysis therapy, the patient's NSSI has worsened.
• Intermittent vertical gaze deviation was noted, prompting further investigation.
• Lack of coordinated care and communication among specialists presents a significant barrier.

Implications:

• This case underscores the challenges in managing complex medical and behavioral comorbidities in individuals with Down syndrome.
• Integrated care models and robust family support systems are crucial for optimizing outcomes.
• Further investigation into potential neurological or rare metabolic causes for refractory NSSI is warranted.